Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study

Journal of Pain ◽

10.1016/j.jpain.2004.09.005 ◽

2005 ◽

Vol 6 (1) ◽

pp. 21-28 ◽

Cited By ~ 110

Author(s):

Martin E. Hale ◽

Chris Dvergsten ◽

Joseph Gimbel

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Phase Iii ◽

Low Back ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of tapentadol ER for chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

Journal of Pain ◽

10.1016/j.jpain.2009.01.321 ◽

2009 ◽

Vol 10 (4) ◽

pp. S50 ◽

Cited By ~ 4

Author(s):

R. Buynak ◽

D. Shapiro ◽

A. Okamoto ◽

I. Van Hove ◽

M. Etropolski

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Phase Iii ◽

Low Back ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

Journal of Pain ◽

10.1016/j.jpain.2009.01.202 ◽

2009 ◽

Vol 10 (4) ◽

pp. S48 ◽

Cited By ~ 5

Author(s):

R. Buynak ◽

D. Shapiro ◽

A. Okamoto ◽

C. Lange ◽

M. Etropolski

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Phase Iii ◽

Low Back ◽

Double Blind ◽

Double Blind Placebo ◽

Gastrointestinal Tolerability ◽

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

Journal of Pain ◽

10.1016/j.jpain.2006.09.011 ◽

2007 ◽

Vol 8 (2) ◽

pp. 175-184 ◽

Cited By ~ 110

Author(s):

Martin E. Hale ◽

Harry Ahdieh ◽

Tina Ma ◽

Richard Rauck

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Controlled Study ◽

Low Back ◽

Efficacy And Safety ◽

Double Blind ◽

A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity

Journal of Pain ◽

10.1016/j.jpain.2009.01.275 ◽

2009 ◽

Vol 10 (4) ◽

pp. S51 ◽

Cited By ~ 3

Author(s):

M. Etropolski ◽

C. Rauschkolb-Löffler ◽

D. Shapiro ◽

A. Okamoto ◽

C. Lange

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Phase Iii ◽

Low Back ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Pain Analysis

A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment

Pain ◽

10.1097/j.pain.0000000000000230 ◽

2015 ◽

Vol 156 (9) ◽

pp. 1660-1669 ◽

Cited By ~ 16

Author(s):

Richard L. Rauck ◽

Martin E. Hale ◽

Almasa Bass ◽

Candace Bramson ◽

Glenn Pixton ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Pain Treatment ◽

Low Back ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

(454) A randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of oxycodone/naloxone extended-release tablets (OXN) in opioid-experienced subjects with chronic low back pain

Journal of Pain ◽

10.1016/j.jpain.2014.01.365 ◽

2014 ◽

Vol 15 (4) ◽

pp. S89 ◽

Cited By ~ 1

Author(s):

J. Green ◽

B. Dain ◽

C. Munera ◽

J. Gimbel ◽

J. Potts ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Multicenter Trial ◽

Low Back ◽

Efficacy And Safety ◽

Double Blind ◽

708 RESULTS OF A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐AND ACTIVE‐CONTROLLED TRIAL OF TAPENTADOL EXTENDED RELEASE FOR CHRONIC LOW BACK PAIN

European Journal of Pain ◽

10.1016/s1090-3801(09)60711-4 ◽

2009 ◽

Vol 13 (S1) ◽

Cited By ~ 1

Author(s):

D.Y. Shapiro ◽

R. Buynak ◽

A. Okamoto ◽

I. Hove ◽

A. Steup ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study

Current Medical Research and Opinion ◽

10.1185/03007995.2012.726216 ◽

2012 ◽

Vol 28 (10) ◽

pp. 1617-1634 ◽

Cited By ~ 19

Author(s):

Michael A. Überall ◽

Gerhard H.H. Mueller-Schwefe ◽

Bernd Terhaag

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Low Back ◽

Modified Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iv

(248) Analgesic efficacy and safety of controlled-release hydrocodone and acetaminophen tablets, dosed twice daily, for moderate to severe mechanical chronic low-back pain: A randomized, double-blind, placebo-controlled withdrawal trial

Journal of Pain ◽

10.1016/j.jpain.2008.01.169 ◽

2008 ◽

Vol 9 (4) ◽

pp. 38

Author(s):

C. Codding ◽

D. Levinsky ◽

M. Hale ◽

J. Thomas ◽

E. Lockhart ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Controlled Release ◽

Chronic Low Back Pain ◽

Analgesic Efficacy ◽

Low Back ◽

Efficacy And Safety ◽

Double Blind ◽